Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Clinical trial NCT06349759 · COMPLETED

Trial details

NCT number: NCT06349759
Sponsor: Ocuphire Pharma, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mesopic Vision Night Vision Loss

Start date: 2024-04-01
Primary completion: 2025-04-17
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.